Guggenheim Capital LLC Sangamo Therapeutics, Inc Transaction History

Guggenheim Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$9.51 - $16.6 $1.44 Million - $2.52 Million	-151,525 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$13.05 - $19.05 $5,220 - $7,620	-400 Reduced 0.26%	151,525 $2.57 Million
Q2 2018 Aug 14, 2018	BUY	$13.9 - $19.8 $742,843 - $1.06 Million	53,442 Added 54.27%	151,925 $2.16 Million
Q1 2018 May 15, 2018	SELL	$16.7 - $26.35 $504,874 - $796,613	-30,232 Reduced 23.49%	98,483 $1.87 Million
Q4 2017 Feb 14, 2018	BUY	$11.6 - $17.35 $1.49 Million - $2.23 Million	128,715	128,715 $2.11 Million

133

86.3M

35.9K

156K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $117M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.